3 Reasons Canopy Growth (TSX:WEED) Stock Is Tanking

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stock has been falling for months. Here’s why

| More on:
Cannabis stocks have fallen.

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has been having a terrible run in 2019. Having sunk to $21 on Wednesday, its returns have officially become negative for the year. The stock got off to a good start early on, rising by 75% in January.

More recently, however, it has been struggling under growing losses and concerns about the quality of its management. Shortly after CEO Bruce Linton was fired, Canopy embarked on a freefall that has continued until today.

The question investors need to ask themselves is whether the stock can ever recover. To answer that question, we need to look at the company’s management and their approach to growth.

Management shake-up

Shortly after Canopy released its Q1 results, the company’s board fired CEO Bruce Linton, saying they were “not happy” with his performance.  The company didn’t give specific reasons, though likely pertain to the company’s growing losses under his leadership.

Not only did Canopy lose enormous sums of money this year, but a major component of the increase in expenses was share-based executive compensation.

When your company is losing money, such an expense can be tough to justify. Although the board has to approve compensation, it may have been unhappy about the amount Linton & co were asking.

Canopy’s biggest loss ever

Speaking of losses, Canopy recently posted an enormous one. In Q1, the company reported a staggering $1.28 billion net-loss, the biggest ever for a cannabis company.

Most of that loss was due to extinguishment of warrants from the company’s Constellation Brands deal–a one-time financing factor that won’t recur.

Nevertheless, it’s still a huge red mark on the balance sheet, and the company’s loss from operations ($123 million) was also enormous. The operating loss increased from $30 million in the same quarter a year before, but was down sequentially.

Revenue growth lower than competitors

It’s no secret that cannabis companies are posting incredible revenue growth. Where 50% year over year is considered exceptional for most industries, marijuana producers have been growing by hundreds of percentage points.

Canopy is no exception, having grown at 260% year over year in its most recent quarter. However, that growth figure is actually on the low end for a marijuana company in 2019. Aphria, for example grew at 969% year-over-year in its most recent quarter, and others are hovering around 300%.

Growth set to slow

A final factor that could be hurting Canopy is the fact that its growth is set to slow.

The most recent quarter’s 260% year-over-year revenue growth is largely due to a sales boost from adult-use cannabis legalization. That’s a one-time event that added tens of millions of dollars to Canopy’s revenue last year.

When Canopy releases earnings this year, it’s comparing one quarter with legal cannabis, to a previous quarter without it. Naturally, year-over-year revenue growth will be massive. When we look at sequential growth, however, things are much more moderated.

That’s because, sequentially, Canopy is comparing one post-legalization quarter to another one. Starting next year, the same will be true of year-over-year comparisons. When that comes to pass, revenue growth rates will slow down considerably.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »